The MELD Score: Limitations and consequences.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The Old and New Methods of Assessing Kidney Function

  2012cited by this paper
• Simultaneous liver-kidney versus liver transplantation alone in patients with end-stage liver disease and kidney dysfunction not on dialysis.

  2011cited by this paper
• The model for end‐stage liver disease allocation system for liver transplantation saves lives, but increases morbidity and cost: a prospective outcome analysis

  2011cited by this paper
• The coagulopathy of chronic liver disease.

  2011cited by this paper
• Increased model for end‐stage liver disease score at the time of liver transplant results in prolonged hospitalization and overall intensive care unit costs

  2010cited by this paper
• Themes of liver transplantation

  2010influential reference
• Liver Transplantation for Hepatocellular Carcinoma in the MELD Era: Leading Roles of MELD Score, AFP Level, and Recipient Age as Predictors of Survival

  2009cited by this paper
• Disparities in Liver Transplantation Before and After Introduction of the MELD Score

  2009influential reference
• Limitations of the MELD score in predicting mortality or need for removal from waiting list in patients awaiting liver transplantation

  2009cited by this paper
• Reduced production of creatinine limits its use as marker of kidney injury in sepsis.

  2009cited by this paper
• Liver transplantation cost in the model for end‐stage liver disease era: Looking beyond the transplant admission

  2009cited by this paper
• Declining Outcomes in Simultaneous Liver-Kidney Transplantation in the MELD Era: Ineffective Usage of Renal Allografts

  2009cited by this paper
• The impact of MELD allocation on simultaneous liver-kidney transplantation

  2009influential reference
• Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK)

  2008cited by this paper
• Declining Outcomes in Simultaneous Liver-Kidney Transplantation in the MELD Era: Ineffective Usage of Renal Allografts

  2008cited by this paper
• Disparities in liver transplantation before and after introduction of the MELD score.

  2008cited by this paper
• Simultaneous Liver–Kidney Transplantation: Evaluation to Decision Making

  2007cited by this paper
• Review article: renal function assessment in cirrhosis – difficulties and alternative measurements

  2007cited by this paper
• Model for end‐stage liver disease (MELD) exception guidelines

  2006cited by this paper
• Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients.

  2006cited by this paper
• Assessing kidney function--measured and estimated glomerular filtration rate.

  2006cited by this paper
• A comparison of liver transplantation outcomes in the pre‐ vs. post‐MELD eras

  2005cited by this paper
• Liver transplant recipient selection: MELD vs. clinical judgment

  2005cited by this paper
• The Economic Impact of MELD on Liver Transplant Centers

  2005cited by this paper
• The Survival Benefit of Liver Transplantation

  2005cited by this paper
• Estimation of glomerular filtration rates before and after orthotopic liver transplantation: Evaluation of current equations

  2004cited by this paper
• Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.

  2004cited by this paper
• Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: A decision analysis

  2004cited by this paper
• WSEAS TRANSACTIONS ON BIOLOGY AND BIOMEDICINE

  2004cited by this paper
• MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.

  2004cited by this paper
• Predicting Outcome After Liver Transplantation: Utility of the Model for End-Stage Liver Disease and a Newly Derived Discrimination Function.

  2004cited by this paper
• Impact of pretransplant diagnosis of hepatocellular carcinoma on cadveric liver allocation in the era of MELD

  2004cited by this paper
• Specific laboratory methodologies achieve higher model for endstage liver disease (MELD) scores for patients listed for liver transplantation

  2004cited by this paper
• The sickest first? Disparities with model for end‐stage liver disease‐based organ allocation: One region's experience

  2003cited by this paper
• MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study

  2003cited by this paper
• Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation1

  2003cited by this paper
• Model for end-stage liver disease (MELD) and allocation of donor livers.

  2003cited by this paper
• Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.

  2002cited by this paper
• Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I

  2002cited by this paper
• Focal lesions in cirrhotic explant livers: Pathological evaluation and accuracy of pretransplantation imaging examinations

  2002cited by this paper
• Identification of patients best suited for combined liver–kidney transplantation: Part II

  2002cited by this paper
• A model to predict survival in patients with end‐stage liver disease

  2001cited by this paper
• Trends in expenditures for Medicare liver transplant recipients

  2001cited by this paper
• The influence of ketoacids on plasma creatinine assays in diabetic ketoacidosis.

  2000cited by this paper
• A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts

  2000cited by this paper
• Comparative studies of rabbit and human recombinant tissue factor reagents.

  1999cited by this paper
• Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.

  1999cited by this paper
• Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.

  1996cited by this paper
• Prothrombin time in liver failure: Time, ratio, activity percentage, or international normalized ratio

  1996cited by this paper
• Assessment of the Validity of the INR System for Patients with Liver Impairment

  1994cited by this paper
• Surgery and portal hypertension.

  1964cited by this paper

• Comparing Jaffe and Enzymatic Methods for Creatinine Measurement at Various Icterus Levels and Their Impacts on Liver Transplant Allocation

  2023cites this paper
• Prediction of lethal outcome in pediatric liver transplantation using duration of mechanical ventilation

  2021cites this paper
• Incentive-Compatible Triaging in Deceased Donor Transplantation

  2021cites this paper
• Prediction of Graft Dysfunction in Pediatric Liver Transplantation by Logistic Regression

  2020cites this paper
• Correlation between APRI Index, MELD Sore and Child Pugh Score in Cirrhosis of Liver

  2018cites this paper
• The corneal transplant score: a simple corneal graft candidate calculator

  2013cites this paper